Intravenous drip. Source: Getty Images Neoadjuvant dd-MVAC improved 5-year overall survival when compared to gemcitabine and cisplatin in a phase 3 trial of patients with MIBC. Dose-dense methotrexate ...
Integrated Therapy for Locally Advanced Bladder Cancer: Final Report of a Randomized Trial of Cystectomy Plus Adjuvant M-VAC Versus Cystectomy With Both Preoperative and Postoperative M-VAC The ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guérin intravesical therapy in non-muscle-invasive bladder cancer. Background: DD-MVAC has shown ...
Hosted on MSN
MVAC: Energy assistance funding to resume
MANKATO, Minn. (KEYC) - After funding was stalled during the government shutdown, help is on the way for those struggling with energy costs. During the shutdown, the Minnesota Valley Action Council ...
Treatment for muscle-invasive bladder cancer called dose-dense MVAC did not improve survival compared with chemotherapy alone, although one drug in the combination faces a shortage. In some patients ...
New research indicates that patients with locally advanced urothelial carcinomas of mixed histology respond better to pre-cystectomy chemotherapy with methotrexate, vinblastine, doxorubicin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results